Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Novel antiarrhythmic agents described by Merck & Co.

Feb. 13, 1997

Novartis launches once-daily hypertension Rx

Feb. 12, 1997

Alexion receives grant for complement inhibitors

Feb. 12, 1997

Sulfonamide derivatives for inhibition of cell adhesion

Feb. 12, 1997

American Home Products describes antiproliferative agents

Feb. 12, 1997

T Cell Sciences awarded second grant for vaccine development

Feb. 11, 1997

ET antagonists reported by Japanese investigators

Feb. 11, 1997

German researchers focus on Na+/H+-exchange inhibitors

Feb. 10, 1997

Chymase inhibitors from Green Cross

Feb. 7, 1997

First Corlopam Renal Program study completed

Feb. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...